Prestige Consumer Healthcare Inc. · NYSE:PBH
Prestige Consumer Healthcare — Merger or Acquisition (March 2026)
20 slides from Prestige Consumer Healthcare's merger presentation, Mar 20, 2026
Slide 1: Announcement of Agreement to Acquire Breathe Right
March 20, 2026 Announcement of Agreement to Acquire Breathe Right
Slide 2: Safe Harbor Disclosure
Safe Harbor Disclosure This presentation contains certain “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding the timing of the closing of the acquisition; the tax benefits from the acquisition; the Company’s ability t
Slide 3: Today's Agenda
Today’s Agenda I. Strategic Rationale II. Portfolio Overview III. Transaction & Financial Highlights IV. The Road Ahead MARCH 2026 ACQUISITION ANNOUNCEMENT 3
Slide 4: I. Strategic Rationale
I. Strategic Rationale MARCH 2026 ACQUISITION ANNOUNCEMENT
Slide 5: Highly Compelling Strategic and Financial Rationale
Highly Compelling Strategic and Financial Rationale ✓ Adds a Leading Global Brand in the Attractive “Better Breathing” Space ✓ Compelling Brand-Building Opportunity Expands Both Category and International Footprint ✓ Well-Aligned with Core Competencies ✓ Accretive Financial Profile and Anticipated S
Slide 6: II. Portfolio Overview
II. Portfolio Overview MARCH 2026 ACQUISITION ANNOUNCEMENT
Slide 7: Scaled Platform of Leading OTC Consumer Healthcare Brands
Scaled Platform of Leading OTC Consumer Healthcare Brands • Synonymous with Better Breathing Solutions Revenue Mix • #1 Nasal Strip with Global Reach • Long-Standing Equity Since the Early 1990s Other Brands ~34% • #1 Most Trusted Children’s Cold Relief Brand by Pharmacists1 ~66% • #2 Branded Oral A
Slide 8: Breathe Right®: The Better Breathing Authority
Breathe Right®: The Better Breathing Authority Product Portfolio Tangible Relief: Immediately Increases Nasal Air Flow By Up to ~30% Breathe Right ® Tan – Stays on Better, Longer Drug-Free Product: Safe to Use with No Side Effects Proprietary Technology: Enabling Superior Experience Strong Brand Equ
Slide 9: An Iconic Global Brand
An Iconic Global Brand Breathe Right is the Clear Category Leader… …With International Reach… (Nasal Strips Market Share) (Revenue Mix by Geography) ~60% Market 71% 29% Share U.S. & International Canada … with Compelling Financial Attributes $125M+ Revenue Strong Revenue Outlook Stable Operating Mod
Slide 10: III. Transaction & Financial Highlights
III. Transaction & Financial Highlights MARCH 2026 ACQUISITION ANNOUNCEMENT
Slide 11: Transaction Overview
Transaction Overview • Acquiring a portfolio of OTC brands centered around Breathe Right® from Foundation Consumer Healthcare • Purchase Price of $1.045 billion in cash, or ~$900 million net of anticipated tax benefits Overview • Generated ~$200 million of revenue and ~$95 million of EBITDA over the
Slide 12: Transaction Meaningfully Strengthens Scale and Financial Profile
Transaction Meaningfully Strengthens Scale and Financial Profile Enhances Prestige Revenue1 Scale … … with Strong Profitability1 ~ +1.2x ~$1,300 ~$1,100 Estimated Pro-Forma1 ~35% Company EBITDA Margin Standalone Pro Forma Top 5 Brands by Estimated Annualized Revenue $0.25+ EPS Accretion (Pro-Forma)
Slide 13: Industry-Leading Free Cash Flow Supports Rapid De-Leveraging
Industry-Leading Free Cash Flow Supports Rapid De-Leveraging Transaction • Transaction is expected to be financed with cash on hand and a new term loan credit facility Financing • Anticipated pro-forma bank-defined net leverage of approximately 4.0x at close Cash • Expect rapid deleveraging consiste
Slide 14: IV. The Road Ahead
IV. The Road Ahead MARCH 2026 ACQUISITION ANNOUNCEMENT
Slide 15: Proven Strategy Delivers Long-Term Performance
Proven Strategy Delivers Long-Term Performance Proven Ability to Execute Value Creation Strategy 1 Investing for Growth with Proven Brand-Building Playbook 2 Superior Business Attributes Drive Strong Free Cash Flow 3 Scalable & Efficient Platform Enables Capital Allocation Optionality Prestige 5 Yea
Slide 16: Repeatable and Consistently Disciplined Approach to M&A
Repeatable and Consistently Disciplined Approach to M&A 2012 2013-14 2014 2015 2016 2021 2025 2026 Select M&A Examples Portfolio Expansion Added Business, Geographic Capabilities Key Brands 11+ Acquisitions in Past 16 Years MARCH 2026 ACQUISITION ANNOUNCEMENT 16
Slide 17: Portfolio & Strategy Well-Positioned for Long-Term Value Creation
Portfolio & Strategy Well-Positioned for Long-Term Value Creation 1 Diversified Portfolio of Leading, Trusted Brands 2 Established Organic Growth Brand-Building Playbook 3 Superior Financial Profile Generating Consistent Free Cash Flow 4 Scalable Platform 5 Organic Growth Reinforced by Proven & Repe
Slide 18: Q&A
Q&A MARCH 2026 ACQUISITION ANNOUNCEMENT
Slide 19: Reconciliation Schedules
Reconciliation Schedules Organic Revenue, Adjusted Net Income & Adjusted EPS Year Ended March 31, 2025 2020 (In Millions) GAAP Total Revenues $ 1,137.8 $ 963.0 Revenue Change CAGR 3.4% Adjustments: Impact of foreign currency exchange rates (0.1%) Impact of acquisitions & divestitures(a) (0.9%) Total
Slide 20: MARCH 2026 ACQUISITION ANNOUNCEMENT
MARCH 2026 ACQUISITION ANNOUNCEMENT
Prestige Consumer Healthcare — Merger or Acquisition (March 2026) on 6ix